New Indications Approved by the FDA for Oncology Drugs.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 226
- Publication type:
- Article
Works matching IS 21641153 AND DT 2022 AND VI 12 AND IP 4
Results: 9
1
2
Sterility of Single-Use Vials When Using a Closed-System Transfer Device.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 220
- By:
- Publication type:
- Article
3
Third-Line Tyrosine Kinase Inhibitor Therapy Results in 16-Year Remission in a Patient with Stage IV Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 216
- By:
- Publication type:
- Article
4
Safety and Efficacy of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients with Cancer and Baseline Renal Dysfunction.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 207
- By:
- Publication type:
- Article
5
The Drug Pricing 'Slippery Slope'.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 203
- By:
- Publication type:
- Article
6
The Link Between Hypoalbuminemia and Oral Tyrosine Kinase Inhibitor Adverse Events in Adults with Malignant Solid Tumors.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 196
- By:
- Publication type:
- Article
7
Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 180
- By:
- Publication type:
- Article
8
CORRECTION.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 179
- Publication type:
- Article
9
Optimal Sequencing of Cancer Treatments an Increasingly Important Question.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 4, p. 178
- By:
- Publication type:
- Article